These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19366601)

  • 1. Kinematic viscosity of therapeutic pulmonary surfactants with added polymers.
    Lu KW; Pérez-Gil J; Taeusch H
    Biochim Biophys Acta; 2009 Mar; 1788(3):632-7. PubMed ID: 19366601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo.
    Lu KW; Taeusch HW; Clements JA
    Exp Lung Res; 2013; 39(4-5):191-200. PubMed ID: 23638643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bulk shear viscosities of endogenous and exogenous lung surfactants.
    King DM; Wang Z; Palmer HJ; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2002 Feb; 282(2):L277-84. PubMed ID: 11792632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of polymers and KL(4) peptide on surface activity of pulmonary surfactant lipids.
    Lu KW; Taeusch HW
    Biochim Biophys Acta; 2010 Jun; 1798(6):1129-34. PubMed ID: 20188696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.
    Taeusch HW; Dybbro E; Lu KW
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):243-9. PubMed ID: 18065212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan decreases surfactant inactivation in vitro.
    Lu KW; Goerke J; Clements JA; Taeusch HW
    Pediatr Res; 2005 Feb; 57(2):237-41. PubMed ID: 15585679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonionic polymers reverse inactivation of surfactant by meconium and other substances.
    William Taeusch H; Lu KW; Goerke J; Clements JA
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1391-5. PubMed ID: 10228100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries.
    Lu KW; Taeusch HW; Robertson B; Goerke J; Clements JA
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1531-6. PubMed ID: 11704608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A freeze-fracture transmission electron microscopy and small angle x-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure.
    Braun A; Stenger PC; Warriner HE; Zasadzinski JA; Lu KW; Taeusch HW
    Biophys J; 2007 Jul; 93(1):123-39. PubMed ID: 17416614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.
    Taeusch HW; Bernardino de la Serna J; Perez-Gil J; Alonso C; Zasadzinski JA
    Biophys J; 2005 Sep; 89(3):1769-79. PubMed ID: 15923228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualizing the analogy between competitive adsorption and colloid stability to restore lung surfactant function.
    Shieh IC; Waring AJ; Zasadzinski JA
    Biophys J; 2012 Feb; 102(4):777-86. PubMed ID: 22385848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Component-specific surface and physiological activity in bovine-derived lung surfactants.
    Notter RH; Wang Z; Egan EA; Holm BA
    Chem Phys Lipids; 2002 Jan; 114(1):21-34. PubMed ID: 11841823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextran or polyethylene glycol added to curosurf for treatment of meconium lung injury in rats.
    Lu KW; Robertson B; Taeusch HW
    Biol Neonate; 2005; 88(1):46-53. PubMed ID: 15767742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-surfactant treatment of meconium-induced acute lung injury.
    Lu KW; William Taeusch H; Robertson B; Goerke J; Clements JA
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):623-8. PubMed ID: 10934097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of mixed monolayers of clinical lung surfactant, serum albumin and hydrophilic polymers.
    Minkov I; Mircheva K; Grozev N; Tz I; Panaiotov I
    Colloids Surf B Biointerfaces; 2013 Jan; 101():135-42. PubMed ID: 22796783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran.
    Ochs M; Schüttler M; Stichtenoth G; Herting E
    Respir Res; 2006 Jun; 7(1):86. PubMed ID: 16756655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of water-soluble polymers on the state of aggregation, vesicle size, and phase transformations in mixtures of phosphatidylcholine and sodium cholate.
    Meyuhas D; Lichtenberg D
    Biophys J; 1996 Nov; 71(5):2613-22. PubMed ID: 8913599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung surfactants and different contributions to thin film stability.
    Hermans E; Bhamla MS; Kao P; Fuller GG; Vermant J
    Soft Matter; 2015 Nov; 11(41):8048-57. PubMed ID: 26307946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels.
    De Backer L; Braeckmans K; Demeester J; De Smedt SC; Raemdonck K
    Nanomedicine (Lond); 2013 Oct; 8(10):1625-38. PubMed ID: 23418856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.